Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Ming

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Journal of the American Academy of Dermatology|February 24, 2024
Pathologic characteristics and clinical outcomes of primary dermal melanomaGabriella N Tortorello, Eric H Li, Cimarron E Sharon, et al.
Journal of the American Academy of Dermatology|February 7, 2021
Association of the Affordable Care Act's Medicaid expansion with the diagnosis and treatment of clinically localized melanoma: A National Cancer Database studyRichard J Straker, Yun Song, Adrienne B Shannon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2004
Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer stagingPhyllis A Gimotty, DuPont Guerry, Michael E Ming, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2013
Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviorsKaren Glanz, Kathryn Volpicelli, Peter A Kanetsky, et al.
Journal of the American Academy of Dermatology|May 5, 2021
Response to a letter to the editor regarding "limitations of using the National Cancer Database to examine the effect of policy change on stage at presentation at the population-level"Richard J Straker, Yun Song, Adrienne B Shannon, et al.
Journal of the American Academy of Dermatology|December 22, 2020
The impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: A single institution experienceAdrienne B Shannon, Cimarron E Sharon, Richard J Straker, et al.
Journal of the American Academy of Dermatology|July 12, 2021
Acral lentiginous melanoma in the era of immune checkpoint blockade and targeted therapy: A National Cancer Database analysisRichard J Straker, Alexandra S Thaler, Adrienne B Shannon, et al.
JAMA Dermatology|July 21, 2018
Timing of Onset of Adverse Cutaneous Reactions Associated With Programmed Cell Death Protein 1 Inhibitor TherapyLeo L Wang, Gopal Patel, Zelma C Chiesa-Fuxench, et al.
Journal of Cutaneous Pathology|May 11, 2016
Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanomaMark C Mochel, Michael E Ming, Sotonye Imadojemu, et al.
Journal of General Internal Medicine|July 1, 2006
Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologistsSuephy C Chen, Michelle L Pennie, Paul Kolm, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Journal of the American Academy of Dermatology|February 24, 2024
Pathologic characteristics and clinical outcomes of primary dermal melanomaGabriella N Tortorello, Eric H Li, Cimarron E Sharon, et al.
Journal of the American Academy of Dermatology|February 7, 2021
Association of the Affordable Care Act's Medicaid expansion with the diagnosis and treatment of clinically localized melanoma: A National Cancer Database studyRichard J Straker, Yun Song, Adrienne B Shannon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2004
Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer stagingPhyllis A Gimotty, DuPont Guerry, Michael E Ming, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2013
Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviorsKaren Glanz, Kathryn Volpicelli, Peter A Kanetsky, et al.
Journal of the American Academy of Dermatology|May 5, 2021
Response to a letter to the editor regarding "limitations of using the National Cancer Database to examine the effect of policy change on stage at presentation at the population-level"Richard J Straker, Yun Song, Adrienne B Shannon, et al.
Journal of the American Academy of Dermatology|December 22, 2020
The impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: A single institution experienceAdrienne B Shannon, Cimarron E Sharon, Richard J Straker, et al.
Journal of the American Academy of Dermatology|July 12, 2021
Acral lentiginous melanoma in the era of immune checkpoint blockade and targeted therapy: A National Cancer Database analysisRichard J Straker, Alexandra S Thaler, Adrienne B Shannon, et al.
JAMA Dermatology|July 21, 2018
Timing of Onset of Adverse Cutaneous Reactions Associated With Programmed Cell Death Protein 1 Inhibitor TherapyLeo L Wang, Gopal Patel, Zelma C Chiesa-Fuxench, et al.
Journal of Cutaneous Pathology|May 11, 2016
Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanomaMark C Mochel, Michael E Ming, Sotonye Imadojemu, et al.
Journal of General Internal Medicine|July 1, 2006
Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologistsSuephy C Chen, Michelle L Pennie, Paul Kolm, et al.
Pageof 8